1. Home
  2. AMBA vs IRON Comparison

AMBA vs IRON Comparison

Compare AMBA & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambarella Inc.

AMBA

Ambarella Inc.

HOLD

Current Price

$50.42

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$60.13

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBA
IRON
Founded
2004
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.3B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
AMBA
IRON
Price
$50.42
$60.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
11
Target Price
$97.25
$103.18
AVG Volume (30 Days)
911.2K
453.7K
Earning Date
02-26-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
37.32
N/A
EPS
N/A
N/A
Revenue
$295,402,000.00
N/A
Revenue This Year
$15.69
N/A
Revenue Next Year
$13.06
$283.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.90
$30.82
52 Week High
$96.69
$99.50

Technical Indicators

Market Signals
Indicator
AMBA
IRON
Relative Strength Index (RSI) 31.98 43.06
Support Level N/A $57.79
Resistance Level $71.00 $61.93
Average True Range (ATR) 2.15 2.56
MACD 0.17 0.54
Stochastic Oscillator 7.16 29.83

Price Performance

Historical Comparison
AMBA
IRON

About AMBA Ambarella Inc.

Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, security cameras, consumer cameras, and industrial and robotic applications. The company's system-on-a-chip designs, based on its proprietary technology platform, are configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: